You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 4, 2024

CLINICAL TRIALS PROFILE FOR BEMPEDOIC ACID; EZETIMIBE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for bempedoic acid; ezetimibe

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03001076 ↗ Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) Completed Esperion Therapeutics Phase 3 2016-11-29 The purpose of this study is to determine if bempedoic acid (ETC-1002) added-on to ezetimibe therapy is effective and safe versus placebo in patients with elevated LDL cholesterol.
NCT03001076 ↗ Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) Completed Esperion Therapeutics, Inc. Phase 3 2016-11-29 The purpose of this study is to determine if bempedoic acid (ETC-1002) added-on to ezetimibe therapy is effective and safe versus placebo in patients with elevated LDL cholesterol.
NCT03051100 ↗ Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C Completed Esperion Therapeutics Phase 2 2017-01-19 The purpose of this study is to determine if triplet therapy with bempedoic acid (ETC-1002) 180mg, ezetimibe 10mg, and atorvastatin 20mg is effective and safe versus placebo in patients with elevated LDL cholesterol.
NCT03051100 ↗ Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C Completed Esperion Therapeutics, Inc. Phase 2 2017-01-19 The purpose of this study is to determine if triplet therapy with bempedoic acid (ETC-1002) 180mg, ezetimibe 10mg, and atorvastatin 20mg is effective and safe versus placebo in patients with elevated LDL cholesterol.
NCT03337308 ↗ A Study Evaluating the Safety and Efficacy of Bempedoic Acid Plus Ezetimibe Fixed-Dose Combination Compared to Bempedoic Acid, Ezetimibe, and Placebo in Patients Treated With Maximally Tolerated Statin Therapy Completed Esperion Therapeutics Phase 3 2017-10-23 The purpose of this study is to determine if Bempedoic Acid (BA) + Ezetimibe (EZE) in a fixed-dose combination (FDC) is effective and safe versus its individual components and placebo in patients with elevated LDL cholesterol treated with maximally tolerated statin therapy.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for bempedoic acid; ezetimibe

Condition Name

Condition Name for bempedoic acid; ezetimibe
Intervention Trials
Hypercholesterolemia 2
Non Alcholic Fatty Liver Disease 1
NSTEMI 1
Statin Adverse Reaction 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for bempedoic acid; ezetimibe
Intervention Trials
Hypercholesterolemia 2
Diabetes Mellitus, Type 2 2
Diabetes Mellitus 2
Hyperlipoproteinemias 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for bempedoic acid; ezetimibe

Trials by Country

Trials by Country for bempedoic acid; ezetimibe
Location Trials
United States 14
India 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for bempedoic acid; ezetimibe
Location Trials
California 2
Virginia 2
North Carolina 2
Kentucky 1
Florida 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for bempedoic acid; ezetimibe

Clinical Trial Phase

Clinical Trial Phase for bempedoic acid; ezetimibe
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for bempedoic acid; ezetimibe
Clinical Trial Phase Trials
Completed 4
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for bempedoic acid; ezetimibe

Sponsor Name

Sponsor Name for bempedoic acid; ezetimibe
Sponsor Trials
Esperion Therapeutics, Inc. 5
Esperion Therapeutics 4
Kaiser Permanente 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for bempedoic acid; ezetimibe
Sponsor Trials
Industry 9
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.